How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
1.5 T Superconductive Magnet MRI Syetem Market
- By Application: Neurology, Orthopedics, Cardiology, Oncology, Abdominal Imaging
- By End User: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Research Institutes
- By Magnet Type: Low-Temperature Superconducting (LTS) Magnets, High-Temperature Superconducting (HTS) Magnets
- By Field Strength: 1.5 Tesla
- By Installation Type: Fixed MRI Systems, Mobile MRI Systems
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Neurology leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 10 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 268 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.167 →
- 12 Company Profiles 10 players: SWOT & benchmarking p.175 →
Full report · locked preview
Everything inside the 1.5 T Superconductive Magnet MRI Syetem Market report
A complete, evidence-based study - 12 chapters and 112 sections covering market size, segmentation across 5 axes, regional analysis and 10 company profiles, forecast to 2033.
Segmentation covered
Application 5
End User 4
Magnet Type 2
Field Strength 1
Installation Type 2
Companies profiled
Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems Corporation
Hitachi Medical Corporation
Fujifilm Healthcare Corporation
United Imaging Healthcare
Samsung Medison
Shimadzu Corporation
Neusoft Medical Systems
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
10 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Canon Medical Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Hitachi Medical Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →Fujifilm Healthcare Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →United Imaging Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Samsung Medison
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Shimadzu Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.202 →Neusoft Medical Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,806M by 2033 · 4.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Neurology31.4
- Orthopedics18.6
- Cardiology24.0
- Oncology16.5
- Abdominal Imaging9.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,120M → $1,531M · 4.0%
Europe$780.3M → $1,063M · 3.9%
Asia Pacific$712.5M → $1,129M · 5.9%
Latin America$441.0M → $577.1M · 3.4%
Middle East and Africa$339.3M → $470.8M · 4.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.402026
4.412027
4.432028
4.442029
4.462030
4.462031
4.482032
4.482033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Siemens Healthineers14.5
- GE Healthcare21.1
- Philips Healthcare8.5
- Canon Medical Systems Corporation4.6
- Hitachi Medical Corporation9.5
- Fujifilm Healthcare Corporation13.7
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Application17.7%
End User29.8%
Magnet Type22.8%
Field Strength17.1%
Installation Type12.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.1
- Europe22.3
- Asia Pacific23.7
- Latin America12.1
- Middle East and Africa9.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Siemens Healthineers | 95 | 83 | 88 | 76 | 79 | 96 | 86 |
| GE Healthcare | 87 | 72 | 91 | 91 | 79 | 92 | 85 |
| Philips Healthcare | 86 | 78 | 67 | 66 | 77 | 78 | 75 |
| Canon Medical Systems Corporation | 73 | 75 | 69 | 75 | 60 | 78 | 72 |
| Hitachi Medical Corporation | 52 | 54 | 60 | 55 | 62 | 74 | 60 |
| Fujifilm Healthcare Corporation | 61 | 69 | 63 | 46 | 62 | 51 | 59 |
| United Imaging Healthcare | 47 | 52 | 45 | 52 | 59 | 48 | 51 |
| Samsung Medison | 37 | 48 | 38 | 56 | 48 | 35 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Siemens Healthineers | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| GE Healthcare | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Philips Healthcare | ✓ | ✓ | − | − | ◐ | ✓ |
| Canon Medical Systems Corporation | ◐ | ✓ | − | ◐ | − | ◐ |
| Hitachi Medical Corporation | ◐ | − | ◐ | − | ◐ | ◐ |
| Fujifilm Healthcare Corporation | ◐ | ◐ | ✓ | − | − | − |
| United Imaging Healthcare | − | ◐ | − | − | − | − |
| Samsung Medison | − | − | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Siemens Healthineers86
2GE Healthcare85
3Philips Healthcare75
4Canon Medical Systems Corporation72
5Hitachi Medical Corporation60
6Fujifilm Healthcare Corporation59
7United Imaging Healthcare51
8Samsung Medison44
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Siemens HealthineersGE Healthcare
Challenger2
Strong scale, closing on the leaders.
Philips HealthcareCanon Medical Systems Corporation
Contender2
Focused players with pockets of strength.
Hitachi Medical CorporationFujifilm Healthcare Corporation
Niche2
Specialists in a single segment or region.
United Imaging HealthcareSamsung Medison
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across 1.5 T Superconductive Magnet MRI Syetem Market — a $416M beachhead inside a $7.29B market.
Beachhead (SOM)$416Mobtainable near-term
Serviceable (SAM)$2.57Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Neurology
Best fit — highest urgency & budget in Application.
Economic buyer79 fit
Orthopedics
Strong fit — clear ROI and a fast path to value.
End user68 fit
Cardiology
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Magnet Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win 1.5 T Superconductive Magnet MRI Syetem Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified20%
Evaluation13%
Closed-won7%
$21.5KCAC
$91KLTV
4.2:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
1.5 T Superconductive Magnet MRI Syetem Market is a resilient opportunity — $7.26B by 2033, compounding at 4.3%.
TAM · 2025$5.16Btoday
TAM · 2033$7.26Bforecast
CAGR4.3%2027–2033
Cumulative$55.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.26BTotal addressable market
SAM$2.71BServiceable available market
SOM$476MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.3% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
10+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.26BLarge & growingTAM by 2033 at 4.3% CAGR
$2.71BServiceable nowreachable with today’s model
$476MBeachhead winobtainable near-term share
10+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.66BBear2.8% CAGR
$7.26BBase4.3% CAGR
$9.29BBull5.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
1.5 T Superconductive Magnet MRI Syetem Market — a $7.72B market by 2033. Plan: grow share from 6.7% to 12.9%.
Market size · 2033$7.72Btotal addressable
Market CAGR9.6%2027–2033
Target share12.9%from 6.7% today
Revenue ambition$996Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.7% | 12.9% | At risk |
| Revenue | $553M | $996M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.1% | 42.8% | Ahead |
| Customer retention | 87.3% | 95.4% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $101M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the 1.5 T Superconductive Magnet MRI Syetem Market conversation — a $1.99B market you can size, segment and defend in minutes.
Market size · 2033$1.99Btotal opportunity
Growth5.1%CAGR to 2033
Addressable buyers1,285+accounts in scope
Typical ROI5.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.8×return on cost, year one
< 3 mopayback period
$75K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
10+players profiled in this market
Coverage includes
Siemens HealthineersGE HealthcarePhilips HealthcareCanon Medical Systems CorporationHitachi Medical CorporationFujifilm Healthcare CorporationUnited Imaging HealthcareSamsung Medison+2 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your 1.5 T Superconductive Magnet MRI Syetem Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
1.5 T Superconductive Magnet MRI Syetem Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →15 ML and 50 ML PP Conical Tubes Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View report1536-Well Microplates Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View report1535nm Q-Switched Lasers Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View report-150℃ Ultra-low Temperature Freezers Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View report1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View report14-Alpha Demethylase Inhibitor Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View report14-3-3 Protein Beta/Alpha (YWHAB) Antibody Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View report14-26F Abdominal Aortic Stent Graft Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View report13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View report1,3-Thiazolidine-2,4-Dione Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View report(1–3)-β-D-Glucan Assay Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View report130kV Microfocus X-ray Source Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.